Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 28

Blued blasts its way onto public markets

New World Development and China Mobile-backed gay social and dating app developer Blued raised $84.8m and has seen its shares nearly double in price post-IPO.

Jul 10, 2020

Branding Engineer marks details for Tokyo listing

The Crooz, InterWorks, MyNavi, Sega Sammy and Vector-backed IT human resources provider could raise up to $21m in its initial public offering.

Jul 9, 2020

Cambricon cashes $368m in initial public offering

Lenovo, iFlytek, Alibaba and Tuling Century-backed AI processor provider Cambricon, valued at $2.5bn in 2018, floated on Shanghai's Star Market.

Jul 8, 2020

Velodyne visualises reverse merger

A year after reportedly hiring banks for an IPO, multi-corporate-backed Velodyne has instead chosen a reverse merger to list on the New York Stock Exchange.

Jul 3, 2020

Nasdaq receives Accolade in $220m IPO

Comcast, McKesson, Humana and Independence Health all scored exits as the health benefits services provider floated in an upscaled offering.

Jul 3, 2020

Lemonade demonstrates $319m flotation

SoftBank, XL Catlin, Allianz and Alphabet-backed casualty and property insurance provider Lemonade priced the initial public offering above its range.

Jul 2, 2020

Shift gears up for reverse merger

The Lithia Motors, BMW and Alliance Ventures-backed automotive e-commerce marketplace is set to go public through a reverse merger with Insurance Acquisition.

Jul 1, 2020

Pandion plans $75m initial public offering

SR One and Roche Venture Fund-backed Pandion Therapeutics will use the proceeds from the offering to advance a lead drug candidate for ulcerative colitis.

Jun 30, 2020

Akouos acquires $213m in initial public offering

The hearing loss treatment developer, which counts Novartis Venture Fund and Partners Innovation Fund as investors, floated above its range.

Jun 29, 2020

Fusion Pharma fetches $213m in IPO

Johnson & Johnson and Varian Medical exited the cancer radiotherapy developer in an upsized initial public offering after $158m in funding.

Jun 29, 2020

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here